• Explore /
  • Poster
  • / Nab-paclitaxel (Nab-P) and gemcitabine (G) first-line chemotherapy (CT) in patients (pts) with metastatic pancreatic cancer (mPC) who relapsed after adjuvant treatment (ADJ T): A “REAL LIFE” study.

Nab-paclitaxel (Nab-P) and gemcitabine (G) first-line chemotherapy (CT) in patients (pts) with metastatic pancreatic cancer (mPC) who relapsed after adjuvant treatment (ADJ T): A “REAL LIFE” study.

Abstract Poster

Authors

null

Guido Giordano

Medical Oncology, San Filippo Neri Hospital, Rome, Rome, Italy

Guido Giordano , Michele Milella , Giovanni Lo Re , Mariacristina Di Marco , Davide Melisi , Alessandro Passardi , Antonio Febbraro , Aldo Iop , Vanja Vaccaro , Luisa Foltran , Paola Bertocchi , Francesca Bergamo , Silvia Vecchiarelli , Elisa Giommoni , Vincenzo Ricci , Maria Bernardetta Aloi , Enrico Vasile , Alberto Zaniboni , Vittorina Zagonel , Ferdinando De Vita

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 396)

DOI

10.1200/JCO.2017.35.4_suppl.396

Abstract #

396

Poster Bd #

J2

Abstract Disclosures

Similar Posters

First Author: Guido Giordano

Poster

2023 ASCO Gastrointestinal Cancers Symposium

First-line chemotherapy regimens associated with survival in advanced pancreatic cancer: A Mexican single-center, real-world study.

First-line chemotherapy regimens associated with survival in advanced pancreatic cancer: A Mexican single-center, real-world study.

First Author: Marytere Herrera

First Author: Fabienne Portales

First Author: Evan Justin Walker